Obesity and Risk of Bladder Cancer: A Dose-Response Meta-Analysis of 15 Cohort Studies
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Epidemiological studies have reported inconsistent association between obesity and risk of bladder cancer, and the dose-response relationship between them has not been clearly defined. METHODS: We carried out a meta-analysis to summarize available evidence from epidemiological studies on this point. Relevant articles were identified by searching the PubMed and Web of Science databases through September 30, 2014. We pooled the relative risks from individual studies using random-effect model, and the dose-response relationship was estimated by using restricted cubic spline model. RESULTS: Fifteen cohort studies with 38,072 bladder cancer cases among 14,201,500 participants were included. Compared to normal weight, the pooled relative risks and corresponding 95% confidence intervals of bladder cancer were 1.07(1.01-1.14) and 1.10(1.06-1.14) for preobese and obesity, with moderate (I² = 37.6%, P = 0.029) and low (I² = 15.5%, P = 0.241) heterogeneities between studies, respectively. In a dose-response meta-analysis, body mass index (BMI) was associated with bladder cancer risk in a linear fashion (P(non-linearity) = 0.467) and the risk increased by 4.2% for each 5 kg/m2 increase. No significant publication bias was found (P = 0.912 for Begg's test, P = 0.712 for Egger's test). CONCLUSIONS: Findings from this dose-response meta-analysis suggest obesity is associated with linear-increased risk of bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persons who are overweight (>25 kg/m2) or obese (>30 kg/m2) may have an increased risk of a variety of cancers, although risk may be modified by age, sex, race, menopausal status, duration of obesity, anthropomorphic distribution of adiposity, and the presence of additional metabolic syndrome components.1730,1732–1738”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1733]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Variably increased risk has been reported for cancers of the breast (postmenopausal) endometrium ovary gall bladder, stomach and esophagus, kidney, thyroid (papillary, follicular, and anaplastic but not medullary), colon, bladder, and pancreas.1733,1734,1739–1752”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1733]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“Publication bias was evaluated by using Egger’s test [30] and Begg’s test [31].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“10 or I(2)>50% was used as a threshold indicating statistically significant heterogeneity) [29].”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374 · cited 1×
“Summary RR estimates with their corresponding 95% confidence intervals were derived by using a random-effect model [28] based on statistically significant heterogeneity.”
MethodDose‐response analyses using restricted cubic spline functions in public health research
Desquilbet, L., & Mariotti, F. (2010) · Statistics in Medicine · doi:10.1002/sim.3841 · Cited by 1,980 · cited 1×
“This was applied by modeling BMI using restricted cubic spline model with three knots (2 spline transformations) chosen at the 10%, 50% and 90% percentiles of the distribution [36].”
MethodBhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., & Smeeth, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60892-8 · Cited by 1,707
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 2×
“Few studies controlled for physical activity[12,14,19] and alcohol consumption Obesity and Bladder Cancer Risk”
BackgroundOrsini, N., Li, R., Wolk, A., Khudyakov, P., & Spiegelman, D. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr265 · Cited by 1,280 · cited 3×
“In the first stage, a restricted cubic spline model was fitted by using generalized leastsquares regression by taking into account the correlation within each set of specific relative risks to estimate the 2 study-level coefficients and the within-study covariance matrix[34,35].”
MethodGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 2×
“In the first stage, a restricted cubic spline model was fitted by using generalized leastsquares regression by taking into account the correlation within each set of specific relative risks to estimate the 2 study-level coefficients and the within-study covariance matrix[34,35].”
MethodPapagiannopoulos, I. A., Sideris, V. I., Boschmann, M., Koutsoni, O. S., & Dotsika, E. N. (2013) · Complementary Medicine Research · doi:10.1159/000357718 · Cited by 1,128
Validity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929 · cited 1×
“Obesity is associated with elevated production of insulin, which is a mitogenic factor that may also enhance tumor growth by increasing free insulin-like growth factor-I[44], which in turn modify cell proliferation, apoptosis and angiogenesis [45], and plays a role in bladder cancer[46, 47].”
BackgroundExtending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analyses
Jackson, D., White, I. R., & Thompson, S. G. (2010) · Statistics in Medicine · doi:10.1002/sim.3602 · Cited by 594 · cited 1×
“In the second stage, we derived the overall estimates with random effects by pooling the studyspecific coefficient estimates and variance/covariance matrices that had been obtained in the first stage [37].”
MethodAune, D., Greenwood, D. C., Chan, D. S. M., Vieira, R., Vieira, A. R., Navarro Rosenblatt, D. A., Cade, J. E., Burley, V. J., & Norat, T. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr398 · Cited by 488 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundAssociations between smoking and body weight in the US population: analysis of NHANES II.
Albanes, D., Jones, D. Y., Micozzi, M. S., & Mattson, M. E. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.4.439 · Cited by 401 · cited 1×
“Although smoking is an established risk factor for bladder cancer [39] and many studies have indicated that smoker’s BMI is lower [40, 41], adjustment for smoking did not affect the association of obesity to bladder cancer in our meta-analysis.”
BackgroundRelation of body mass index to cancer risk in 362,552 Swedish men
Samanic, C., Chow, W.-H., Gridley, G., Jarvholm, B., & Fraumeni, J. F. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0023-9 · Cited by 381 · cited 4×
“The summary RRs for preobese ranged from a low of 1.05 (95%CI 0.99–1.12) after omitting the study by Koebnick et al.[12] to a high of 1.08(95%CI 1.02–1.15) after omitting the study by Samanic et al.[20].”
BackgroundMethodInfluentialObesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria
Rapp, K., Schroeder, J., Klenk, J., Stoehr, S., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., & Weiland, S. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602819 · Cited by 332
Body mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis
Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0832 · Cited by 321 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundObesity and cancer risk among white and black United States veterans
Samanic, C., Gridley, G., Chow, W.-H., Lubin, J., Hoover, R. N., & Fraumeni, J. F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000016573.79453.ba · Cited by 318
Mechanisms of Disease: the epidemiology of bladder cancer
Pelucchi, C., Bosetti, C., Negri, E., Malvezzi, M., & La Vecchia, C. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0510 · Cited by 267 · cited 1×
“Established risk factors for bladder cancer include cigarette smoking, schistosomal infection, occupational exposure to specific carcinogens such as aromatic amines, drinking tap water with arsenic, and familial history of bladder cancer [2].”
BackgroundThe predictive validity of body mass index based on self-reported weight and height.
Kuskowska-Wolk, A., Karlsson, P., Stolt, M., & Rössner, S. (1989) · PubMed · Cited by 262
Weight control and physical activity in cancer prevention
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00046.x · Cited by 223
Heikkila, K., Nyberg, S. T., Theorell, T., Fransson, E. I., Alfredsson, L., Bjorner, J. B., Bonenfant, S., Borritz, M., Bouillon, K., Burr, H., et al. (2013) · BMJ · doi:10.1136/bmj.f165 · Cited by 219
Amadou, A., Ferrari, P., Muwonge, R., Moskal, A., Biessy, C., Romieu, I., & Hainaut, P. (2013) · Obesity Reviews · doi:10.1111/obr.12028 · Cited by 214
Changes associated with quitting cigarette smoking: The Framingham Study
Gordon, T., Kannel, W. B., Dawber, T. R., & McGee, D. (1975) · American Heart Journal · doi:10.1016/0002-8703(75)90320-8 · Cited by 206 · cited 1×
“Although smoking is an established risk factor for bladder cancer [39] and many studies have indicated that smoker’s BMI is lower [40, 41], adjustment for smoking did not affect the association of obesity to bladder cancer in our meta-analysis.”
BackgroundBody mass index and cancer risk in Korean men and women
Jee, S. H., Yun, J. E., Park, E. J., Cho, E. R., Park, I. S., Sull, J. W., Ohrr, H., & Samet, J. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23719 · Cited by 199
Harriss, D. J., Atkinson, G., George, K., Tim Cable, N., Reilly, T., Haboubi, N., Zwahlen, M., Egger, M., Renehan, A. G., & the C‐CLEAR group (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.01766.x · Cited by 197 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundOverweight, Obesity and Endometrial Cancer Risk: Results from a Systematic Review and Meta-Analysis
Zhang, Y., Liu, H., Yang, S., Zhang, J., Qian, L., & Chen, X. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000047 · Cited by 171 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundWang, F., & Xu, Y. (2014) · International Journal of Cancer · doi:10.1002/ijc.28813 · Cited by 163 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundZHAO, H., GROSSMAN, H. B., SPITZ, M. R., LERNER, S. P., ZHANG, K., & WU, X. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)63999-7 · Cited by 137 · cited 1×
“Obesity is associated with elevated production of insulin, which is a mitogenic factor that may also enhance tumor growth by increasing free insulin-like growth factor-I[44], which in turn modify cell proliferation, apoptosis and angiogenesis [45], and plays a role in bladder cancer[46, 47].”
BackgroundSmith, M., Zhou, M., Whitlock, G., Yang, G., Offer, A., Hui, G., Peto, R., Huang, Z., & Chen, Z. (2008) · International Journal of Cancer · doi:10.1002/ijc.23198 · Cited by 136 · cited 1×
“In the past decades, extensive evidence suggested potential associations between obesity and many cancers [3–10], it is convincing for obesity as a risk factor for cancers of esophagus [4], pancreas [5], colon and rectum [6], endometrium [7,8], kidney [9],and postmenopausal breast[10].”
BackgroundNagano, J., Kono, S., Preston, D. L., Moriwaki, H., Sharp, G. B., Koyama, K., & Mabuchi, K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<132::aid-ijc21>3.0.co;2-m · Cited by 130
Body Mass Index, Physical Activity, and Bladder Cancer in a Large Prospective Study
Koebnick, C., Michaud, D., Moore, S. C., Park, Y., Hollenbeck, A., Ballard-Barbash, R., Schatzkin, A., & Leitzmann, M. F. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0026 · Cited by 121 · cited 4×
“The summary RRs for preobese ranged from a low of 1.05 (95%CI 0.99–1.12) after omitting the study by Koebnick et al.[12] to a high of 1.08(95%CI 1.02–1.15) after omitting the study by Samanic et al.[20].”
BackgroundMethodInfluentialLiu, Q., Cook, N., Bergström, A., & Hsieh, C. (2009) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2009.05.001 · Cited by 112 · cited 1×
“Because the reference of exposure are different or not zero across studies, centered dose levels (each original non-reference dose minus the reference dose within a study) was used for summarizing dose-response relation[33].”
MethodRisk factors for urinary bladder carcinoma in postmenopausal women: The Iowa Women's Health Study
Tripathi, A., Folsom, A. R., & Anderson, K. E. (2002) · Cancer · doi:10.1002/cncr.10975 · Cited by 106
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
Probst-Hensch, N. M., Wang, H., Goh, V. H. H., Seow, A., Lee, H.-P., & Yu, M. C. (2003) · PubMed · doi:10.5167/uzh-34578 · Cited by 103 · cited 1×
“Obesity is associated with elevated production of insulin, which is a mitogenic factor that may also enhance tumor growth by increasing free insulin-like growth factor-I[44], which in turn modify cell proliferation, apoptosis and angiogenesis [45], and plays a role in bladder cancer[46, 47].”
BackgroundANDREWS, B., SHARIAT, S. F., KIM, J.-H., WHEELER, T. M., SLAWIN, K. M., & LERNER, S. P. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65348-7 · Cited by 102
Hilmy, M., Bartlett, J. M. S., Underwood, M. A., & McMillan, D. C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602406 · Cited by 100 · cited 1×
“, leptin, adiponectin) [48], which may play a role in bladder carcinogenesis to bladder cancer mortality [49, 50].”
BackgroundIl’yasova, D., Hertz‐Picciotto, I., Peters, U., Berlin, J. A., & Poole, C. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-5025-x · Cited by 87 · cited 1×
“When the extreme BMI categories were open-ended, we used the width of the adjacent close-ended category to estimate the midpoints [32].”
MethodObesity and Risk of Bladder Cancer: A Meta-analysis of Cohort Studies
Qin, Q., Xu, X., Wang, X., & Zheng, X.-Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.3117 · Cited by 85 · cited 2×
“When results were combined in a meta-analysis published in 2013 [26], obesity was associated with a 10% increase in risk of bladder cancer.”
ResultReproductive factors, exogenous hormone use and bladder cancer risk in a prospective study
Cantwell, M. M., Lacey, J. V., Schairer, C., Schatzkin, A. G., & Michaud, D. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22175 · Cited by 82
Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
Larsson, S. C., Andersson, S., Johansson, J., & Wolk, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.012 · Cited by 82
Häggström, C., Stocks, T., Rapp, K., Bjørge, T., Lindkvist, B., Concin, H., Engeland, A., Manjer, J., Ulmer, H., Selmer, R., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25521 · Cited by 77
Holick, C. N., Giovannucci, E. L., Stampfer, M. J., & Michaud, D. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22142 · Cited by 76
Andreotti, G., Hou, L., Beane Freeman, L. E., Mahajan, R., Koutros, S., Coble, J., Lubin, J., Blair, A., Hoppin, J. A., & Alavanja, M. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9603-9 · Cited by 59 · cited 1×
“[12,14,19,22], but 12 studies [11–15,17–21,23,24]controlled for cigarette smoking.”
BackgroundBody mass index and cancer incidence: the FINRISK study
Song, X., Pukkala, E., Dyba, T. A., Tuomilehto, J., Moltchanov, V., Männistö, S., Jousilahti, P., & Qiao, Q. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9934-z · Cited by 44
Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines
Iwamura, M., Ishibe, M., Sluss, P. M., & Cockett, A. T. �. (1993) · Urological Research · doi:10.1007/bf00295188 · Cited by 36 · cited 1×
“Obesity is associated with elevated production of insulin, which is a mitogenic factor that may also enhance tumor growth by increasing free insulin-like growth factor-I[44], which in turn modify cell proliferation, apoptosis and angiogenesis [45], and plays a role in bladder cancer[46, 47].”
BackgroundWeight control and physical activity
Vainio, H. (2002) · Cited by 27
Cause–effect? Understanding the risk factors associated with bladder cancer
Bachir, B. G., & Kassouf, W. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.140 · Cited by 19 · cited 1×
“Although smoking is an established risk factor for bladder cancer [39] and many studies have indicated that smoker’s BMI is lower [40, 41], adjustment for smoking did not affect the association of obesity to bladder cancer in our meta-analysis.”
Background
Cited by
Epidemiology of Bladder Cancer
Saginala, K., Barsouk, A., Aluru, J. S., Rawla, P., Padala, S. A., & Barsouk, A. (2020) · Medical Sciences · doi:10.3390/medsci8010015 · Cited by 838
“This risk was found to be independent of smoking, physical activity, alcohol or diet [48].”
BackgroundEpidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
Cumberbatch, M. G. K., Jubber, I., Black, P. C., Esperto, F., Figueroa, J. D., Kamat, A. M., Kiemeney, L., Lotan, Y., Pang, K., Silverman, D. T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.09.001 · Cited by 820
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M. J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., & Tsilidis, K. K. (2017) · BMJ · doi:10.1136/bmj.j477 · Cited by 803
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
van Hoogstraten, L. M. C., Vrieling, A., van der Heijden, A. G., Kogevinas, M., Richters, A., & Kiemeney, L. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00744-3 · Cited by 375
Metadata
- Authors
- Sun, J.-W., Zhao, L.-G., Yang, Y., Ma, X., Wang, Y.-Y., & Xiang, Y.-B.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Xiang, Yong-Bing
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-24
- Volume
- 10
- Issue
- 3
- Pages
- e0119313
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4372289
- OpenAlex
- W2074502199
- Cited by
- 133
- References
- 54
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 13 · 2023: 21 · 2022: 10 · 2021: 16 · 2020: 14 · 2019: 12 · 2018: 16 · 2017: 12 · 2016: 6 · 2015: 2
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- obesity, bladder cancer, body mass index, dose-response relationship, cancer risk, pre-obesity, linear association
- MeSH terms
- Adult, Urinary Bladder Neoplasms, Female, Humans, Male, Obesity, Risk Factors, Cohort Studies, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.